Canada
Study will evaluate psilocybin efficacy in healthcare workers with mental health challenges related to pandemic
Hi, what are you looking for?
Mugglehead Investment Magazine
Psychedelics
Canada
Film screening was followed by audience Q&A session hosted by director
Canada
New clinical research will assess efficacy of IV formulation for the treatment of strokes
Canada
Company believes it has completed the largest mushroom harvest Canada has ever seen
News
The study assessed differences between psilocybin and escitalopram on common signs in MDD
Psychedelics
Free virtual conference will discuss unique requisites of psychedelic clinical development
Canada
Patient participated in ketamine and psilocybin sessions through the Special Access Program from Health Canada
Canada
Clinical trial will be conducted as part of the ATMA Journey Centre's psychedelic-assisted therapist training program
Psychedelics
Influencing policies, cataloguing proof of efficacy and assisting veterans integration processes will be ideal outcomes from partnership
Canada
Discovery of new drugs follows company decision to extend research outside of tryptamine class, i.e. psilocybin and DMT
